Thijs Cohen Tervaert

Thijs Cohen Tervaert is a Partner at INKEF Capital based in Amsterdam, Netherlands. Before joining the venture capital firm, he earned his Doctor of Medicine from Leiden University and worked as a strategy consultant at Boston Consulting Group, focusing on the healthcare and technology sectors. In 2014, he also helped establish the Amsterdam Health and Technology Institute. He has invested in more than 10 early-stage startups and currently holds board positions at several life sciences companies, including iOnctura, ViCentra, and Castor. His portfolio track record includes notable exits such as the acquisition of Aidence by RadNet and the sale of Calypso Biotech to Novartis, contributing to INKEF Capital's broader portfolio of 77 investments and 15 exits. Tervaert leverages his clinical and consulting expertise to lead early-stage investments across therapeutics, digital health, and medical devices.